Advertisement
Screener

Tobira Therapeutics, Inc. Inventory Write-down

Tobira Therapeutics, Inc. Inventory Write-down

Tobira Therapeutics, Inc. reported Inventory Write-down of $8.20 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:InventoryWriteDown · last filed 2015-02-12

  • Tobira Therapeutics, Inc. inventory write-down for the quarter ending 2014-12-31 was $0.00.
  • Tobira Therapeutics, Inc. inventory write-down for fiscal 2014 was $8.20M.
Period endInventory Write-down 3 monthInventory Write-down 9 monthInventory Write-down 12 month
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
$8.20M
10-K · filed 2015-02-12
2014-09-30$8.20M
10-Q · filed 2014-11-06